Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | GBA1 | P04062 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9876657 | 0.89 | ALDH1A1 (0.70) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL5567042 | 0.88 | ALDH1A1 (0.75) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL8213969 | 0.86 | ALDH1A1 (0.72) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL7201051 | 0.84 | ALDH1A1 (0.86) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL7094852 | 0.84 | ALDH1A1 (0.79) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL2627771 | 0.84 | ALDH1A1 (0.68) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL7093365 | 0.82 | ALDH1A1 (0.77) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL7097551 | 0.82 | ALDH1A1 (0.77) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL7092896 | 0.82 | ALDH1A1 (0.77) | ALDH1A1KMT2AMEN1CA12CA9 | |
| SCHEMBL7095193 | 0.82 | ALDH1A1 (0.77) | ALDH1A1KMT2AMEN1CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638643-A | Iron death inhibitor targeting endoplasmic reticulum as well as preparation method and application thereof | 山东中医药大学附属医院 | 2025-03-18 | — | — | CN | claimed |
| CN-111073279-A | Formula and preparation method of nylon pipe with high pressure-bearing capacity | 无锡殷达尼龙有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-111004503-A | Formula of nylon hose material | 无锡殷达尼龙有限公司 | 2020-04-14 | — | — | CN | claimed |
| EP-0789699-B1 | SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | RHONE POULENC RORER SA (FR) | 1999-03-17 | — | — | EP | claimed |
| CN-119638643-A | Iron death inhibitor targeting endoplasmic reticulum as well as preparation method and application thereof | 山东中医药大学附属医院 | 2025-03-18 | — | — | CN | disclosed |
| CN-115843271-B | Indole derivatives and their use for the treatment of cancer | 克洛德贝纳尔-里昂第一大学 | 2024-08-13 | — | — | CN | disclosed |
| US-20230278983-A1 | INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2023-09-07 | — | — | US | disclosed |
| US-20230278983-A1 | INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2023-09-07 | — | — | US | disclosed |
| CN-115843271-A | Indole derivatives and their use for the treatment of cancer | 克洛德贝纳尔-里昂第一大学 | 2023-03-24 | — | — | CN | disclosed |
| EP-2423201-B1 | Luminescent macrocyclic lanthanide complexes | UNIV CALIFORNIA (US) | 2017-10-04 | — | — | EP | disclosed |
| US-9556122-B2 | Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-01-31 | — | — | US | disclosed |
| CN-102459197-B | Be applicable to treatment response thrombotonin 5-HT 6n-phenyl-(piperazinyl or homopiperazine the base)-benzsulfamide of the illness of the adjustment of acceptor or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compound | ABBVIE (US) | 2015-08-19 | — | — | CN | disclosed |
| WO-2011033009-A1 | N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-03-24 | — | — | WO | disclosed |
| US-20100015725-A1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-01-21 | — | — | US | disclosed |
| US-20100015725-A1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-01-21 | — | — | US | disclosed |
| US-20090143582-A1 | Process for making n-(diphenylmethyl)piperazines | SYNTHON BV (NL) | 2009-06-04 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| WO-2008063721-A2 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | SSB, HACD3, CLTA | ALDH1A1 4586/4885KMT2A 3655/4885MEN1 1772/4885 |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | ALDH1A1 2661/4885KMT2A 2796/4885MEN1 4346/4885 |
| US-20230278983-A1 | INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER | CSNK2A1, IDO1, CSNK2A3 | ALDH1A1 995/4885KMT2A 574/4885MEN1 2477/4885 |
| US-20100015725-A1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | PLPBP, HPD, LASP1 | ALDH1A1 411/4885KMT2A 3670/4885MEN1 1167/4885 |
| US-20090143582-A1 | Process for making n-(diphenylmethyl)piperazines | CYP51A1, CYP3A5, CYP4Z1 | ALDH1A1 2312/4885KMT2A 659/4885MEN1 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.